Year: 2010
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Corticobasal syndrome (CBS) can be associated with different underlying pathologies that are difficult to predict based on clinical presentation. The aim of this study was to determine whether patterns of atrophy on imaging could be useful to help predict underlying pathology in CBS. METHODS: This was a case-control study of 24 patients with CBS who had undergone MRI during life and came to autopsy. Pathologic diagnoses included frontotemporal lobar degeneration (FTLD) with TDP-43 immunoreactivity in 5 (CBS-TDP), Alzheimer disease (AD) in 6 (CBS-AD), corticobasal degeneration in 7 (CBS-CBD), and progressive supranuclear palsy in 6 (CBS-PSP). Voxel-based morphometry and atlas-based parcellation were used to assess atrophy across the CBS groups and compared to 24 age- and gender-matched controls. RESULTS: All CBS pathologic groups showed gray matter loss in premotor cortices, supplemental motor area, and insula on imaging. However, CBS-TDP and CBS-AD showed more widespread patterns of loss, with frontotemporal loss observed in CBS-TDP and temporoparietal loss observed in CBS-AD. CBS-TDP showed significantly greater loss in prefrontal cortex than the other groups, whereas CBS-AD showed significantly greater loss in parietal lobe than the other groups. The focus of loss was similar in CBS-CBD and CBS-PSP, although more severe in CBS-CBD. CONCLUSIONS: Imaging patterns of atrophy in CBS vary according to pathologic diagnosis. Widespread atrophy points toward a pathologic diagnosis of FTLD-TDP or AD, with frontotemporal loss suggesting FTLD-TDP and temporoparietal loss suggesting AD. On the contrary, more focal atrophy predominantly involving the premotor and supplemental motor area suggests CBD or PSP pathology.
Source: Neurology
Institutions: Mayo Clinic, Mayo Clinic in Florida
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Dana Foundation, Mayo Foundation for Medical Education and Research, National Institutes of Health, U.S. Public Health Service, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute on Deafness and Other Communication Disorders, National Institute of Neurological Disorders and Stroke, National Institute of Environmental Health Sciences, National Center for Research Resources
Awards: G1175997899, Neuropsychology of Dementia with Lewy Bodies, PIB PET Scanning in Speech and Language Based Dementias, National Alzheimer's Coordinating Center, Alzheimers Disease Patient Registry, Einstein Aging Study, Genetics and Molecular Biology of Parkinsonism, Evaluating and Extending Our Hypothetical Model of Alzheimer's Biomarkers, Alzheimer's Disease Neuroimaging Initiative, Understanding the role of TDP-43 in Alzheimer’s disease and FTLD, G5884129571, Florida Alzheimer's Disease Research, G659427325, Frontotemporal degeneration: a basis for clinical trials, EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM, Tau and Neurodegeneration II: A therapeutic target, Genetic Consortium for Late Onset Alzheimer's Disease, Molecular Epidemiology of Parkinson's Disease, The ARIC and Neurocognitive Longitudinal Study, G8474290341, G8925084847, G9000038603, Mayo Alzheimer's Disease Research Center
OpenAlex ID: W1998433809
